Magenta therapeutics to participate in the credit suisse 31st annual healthcare conference

Cambridge, mass., nov. 01, 2022 (globe newswire) -- magenta therapeutics (nasdaq: mgta), a clinical-stage biotechnology company developing novel medicines designed to bring the curative power of stem cell transplant to more patients, today announced that the company will present at the credit suisse 31st annual healthcare conference being held november 7-10, 2022.
DNTH Ratings Summary
DNTH Quant Ranking